Posted innews Oncology Respiratory
Evaluating Optimal Corticosteroid Duration for Mild Immune-Related Pneumonitis: Insights from a Randomized Trial
A randomized trial shows that a 6-week corticosteroid taper is superior to a 3-week taper for mild immune-related pneumonitis, establishing 6 weeks as the evidence-based standard for short-term treatment success.